TLR4 and pulmonary hypertension: These data suggest that human MSCs ameliorated right ventricular hypertrophy and pulmonary hypertension in the prenatal LPS- and neonatal hyperoxia-treated rats by suppressing TLR4 expression through paracrine effects.